Can-Fite BioPharma (CANF) Operating Leases (2018 - 2025)
Can-Fite BioPharma's (CANF) quarterly Operating Leases came in at $15000.0 in Q4 2025, down 70.59% YoY from $51000.0 in Q4 2024, and down 54.55% on a QoQ basis from $33000.0 in Q2 2025.
Can-Fite BioPharma (CANF) Operating Leases (2018 - 2025) Analysis & Trends
Can-Fite BioPharma (CANF) has 8 years of Operating Leases data on file, last reported at $15000.0 in Q4 2025.
- Quarterly Operating Leases fell 70.59% year-over-year to $15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15000.0 (down 70.59% YoY) and the FY2025 annual result came in at $15000.0, down 70.59% from the prior year.
- Operating Leases slipped to $15000.0 in Q4 2025, from $33000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $71000.0 in Q4 2021 to a low of $6000.0 in Q1 2023.
- A 5-year average of $30250.0 and a median of $23500.0 in 2021 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 88.89% — and 2024, when it jumped 292.31%.
- Tracing CANF's Operating Leases over 5 years: stood at $71000.0 in 2021, then tumbled by 80.28% to $14000.0 in 2022, then retreated by 7.14% to $13000.0 in 2023, then jumped by 292.31% to $51000.0 in 2024, then plunged by 70.59% to $15000.0 in 2025.
- The last three Operating Leases figures came in at $15000.0 (Q4 2025), $33000.0 (Q2 2025), and $51000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Can-Fite BioPharma | 2.77 Mn | -8.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Jun 30, 2025 | 33,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Dec 31, 2020 | 24,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Dec 31, 2019 | 39,000.00 |
| Dec 31, 2018 | 19,000.00 |